Pisgah Labs announced the May 18, 2010 issuance of US Patent 7,718,649. This patent demystifies the physical states of Imipramine Pamoate drug substances. The patent also covers methods of manufacturing, purifying and use of the drug in pharmaceutical preparations and marks the first allowance in a related series of applications pending before the United States Patent and Trademark Office. <http://www.therapeuticsdaily.com/news/article.cfm?contentValue=723405&contentType=newsarchive&channelID=26>http://www.therapeuticsdaily.com/news/article.cfm?contentValue=723405&contentType=newsarchive&channelID=26 "People Who experience mood swings, fear, voices and visions"